Publications by authors named "Jose J Illaramendi"
Background: Trastuzumab combined with cytotoxic agents presents encouraging results in metastatic breast cancer (MBC), but cardiac toxicity limits some combinations. The synergism shown with trastuzumab and the favorable tolerability profile of vinorelbine provided the rationale for investigating this combination.
Patients And Methods: Patients with HER2-positive MBC who had received <2 lines of chemotherapy for metastatic disease were included.